Impact of Baseline Renal Function on the Efficacy and Safety of Aliskiren Added to Losartan in Patients With Type 2 Diabetes and Nephropathy

OBJECTIVE: Proteinuric diabetic patients with reduced glomerular filtration rate (GFR) are at high risk of renal and cardiovascular disease progression and treatment-related adverse events. This post hoc analysis assessed the efficacy and safety of aliskiren added to the maximal recommended dose of...

Descripción completa

Detalles Bibliográficos
Autores principales: Persson, Frederik, Lewis, Julia B., Lewis, Edmund J., Rossing, Peter, Hollenberg, Norman K., Parving, Hans-Henrik
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963484/
https://www.ncbi.nlm.nih.gov/pubmed/20693353
http://dx.doi.org/10.2337/dc10-0833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963484/
https://www.ncbi.nlm.nih.gov/pubmed/20693353
http://dx.doi.org/10.2337/dc10-0833

Ejemplares similares